Lisa Wray

Children's Hospital of Philadelphia — United States

Medicine · Health Sciences

14h-index1.1kcitations42works3.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(20), Acute Lymphoblastic Leukemia research(13), Hematopoietic Stem Cell Transplantation(6), Childhood Cancer Survivors' Quality of Life(5), Hemoglobinopathies and Related Disorders(4)

Publications42 total

Next Generation Sequencing Minimal Residual Disease in Pediatric B-ALL after CD19 and/or CD22 CAR T-cell Therapy: Depth and Kinetics of Response Predict Relapse Risk.
Transplantation and Cellular Therapy·2026
High Rates of Clinically Significant Late Infections and Recurrent Sinopulmonary Disease in Long-Term Survivors after CD19 CAR T-cell Therapy for Pediatric B-ALL
Transplantation and Cellular Therapy·2026
Hematopoietic cell transplantation after CD19-directed CAR T-cell therapy for remission consolidation or relapse treatment in pediatric acute lymphoblastic leukemia
Haematologica·2025Open Access
ALTERNATIVE DONOR PERIPHERAL STEM CELL TRANSPLANTATION WITH TCRΑΒ/CD19 DEPLETION FOR PEDIATRIC PATIENTS WITH BONE MARROW FAILURE
EJC Paediatric Oncology·2025Open Access
Humanized CD19 chimeric antigen receptor (CAR) T-cell therapy for high-risk and post-CAR relapse of B-cell acute lymphoblastic leukemia
Blood·2025
CD19 CAR T cell therapy is an effective strategy for first CNS relapse in pediatric b ALL
Blood·2025Open Access
CD123-directed chimeric antigen receptor T-cell (CART123) therapy for relapsed/refractory pediatric acute myeloid leukemia
Blood·2025
Outcomes of Unrelated Donor Stem Cell Transplantation with Partial T Cell Depletion for Pediatric Patients with Hemoglobinopathies
Transplantation and Cellular Therapy·2025· 2 cited
CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapy
Journal for ImmunoTherapy of Cancer·2025· 11 citedOpen Access
Post-Approval, Real-World Experience with Betibeglogene Autotemcel for Transfusion-Dependent Beta Thalassemia
Transplantation and Cellular Therapy·2025· 1 cited
Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy
Blood Advances·2024· 4 citedOpen Access
Quadriparesis and paraparesis following chimeric antigen receptor T-cell therapy in children and adolescents
Blood·2024· 15 citedOpen Access
Reduced toxicity matched sibling bone marrow transplant results in excellent outcomes for severe congenital neutropenia
Frontiers in Immunology·2024· 3 citedOpen Access
Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia
Blood Advances·2024· 25 citedOpen Access
Outcomes of Unrelated Partial T Cell Depleted Stem Cell Transplantation for Patients with Hemoglobinopathies
Transplantation and Cellular Therapy·2024· 1 cited
Pilot Study of Unrelated Donor (URD) Peripheral Stem Cell Transplant (PSCT) with CD45RA-Depleted Addback Following TCRab/CD19 Depletion in Pediatric Patients with Hematologic Malignancies
Transplantation and Cellular Therapy·2024
Outcomes and Toxicities after Allogeneic Hematopoietic Cell Transplant for Remission Consolidation or Relapse Therapy after CD19 Chimeric Antigen Receptor T Cell Therapy in Children and Young Adults with Acute Lymphoblastic Leukemia
Blood·2023Open Access
Evaluation of Children with Malignancies for Blood and Marrow Transplantation: A Report from the ASTCT Committee on Practice Guidelines
Transplantation and Cellular Therapy·2023· 11 citedOpen Access
Matched Sibling Donor Bone Marrow Transplant with Busulfan + Fludarabine Conditioning Results in Excellent Outcomes for Severe Congenital Neutropenia
Transplantation and Cellular Therapy·2023· 1 citedOpen Access
CD22-Targeted CAR-Modified T-Cells Safely Induce Remissions in Children and Young Adults with Relapsed, CD19-Negative B-ALL after Treatment with CD19-Targeted CAR T-Cells
Blood·2022· 6 cited
page 1 of 3Next →

Frequent Co-authors

Stephan A. Grupp(29), Regina M. Myers(24), Amanda M. DiNofia(24), Allison Barz Leahy(22), Shannon L. Maude(22), Yimei Li(20), Colleen Callahan(19), Susan R. Rheingold(19), Richard Aplenc(18), Diane Baniewicz(18), Stephan Kadauke(11), Caitlin W. Elgarten(11), Timothy S. Olson(10), Caroline Diorio(9), Carl H. June(8), Hongyan Liu(8), Susan McClory(8), Stephen P. Hunger(7), Gerald Wertheim(6), Kaitlin J. Devine(6)